Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 13;118(10):1626-42.
doi: 10.1161/CIRCRESAHA.116.307475.

Pharmacological Strategies to Retard Cardiovascular Aging

Affiliations
Review

Pharmacological Strategies to Retard Cardiovascular Aging

Irene Alfaras et al. Circ Res. .

Abstract

Aging is the major risk factor for cardiovascular diseases, which are the leading cause of death in the United States. Traditionally, the effort to prevent cardiovascular disease has been focused on addressing the conventional risk factors, including hypertension, hyperglycemia, hypercholesterolemia, and high circulating levels of triglycerides. However, recent preclinical studies have identified new approaches to combat cardiovascular disease. Calorie restriction has been reproducibly shown to prolong lifespan in various experimental model animals. This has led to the development of calorie restriction mimetics and other pharmacological interventions capable to delay age-related diseases. In this review, we will address the mechanistic effects of aging per se on the cardiovascular system and focus on the prolongevity benefits of various therapeutic strategies that support cardiovascular health.

Keywords: aging; calorie restriction; cardiovascular diseases; pharmacological strategies; prevention.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Pharmacological strategies to combat cardiovascular aging
Age-associated changes in cardiac and vascular properties (depicted in the inner red circle) can be delayed by targeting the related pathways (in the middle yellow circle) with small molecules (represented in the outer blue circle). Some of the pharmacological strategies highlighted in the diagram (bold and underlined) have been shown to improve longevity in healthy mammals. AMPK, 5’ adenosine monophosphate-activated protein kinase; Ang-II, angiotensin II; AT1, angiotensin II receptor, type 1; Chol, cholesterol; GH, growth hormone; iACE, inhibitors of angiotensin-converting enzyme; IGF-1, insulin-like growth factor-1; mTOR, mechanistic target of rapamycin; NO, nitric oxide; NOS, nitric oxide synthase; Nrf2, NF-E2-related factor 2; PARP-1, poly (ADP-ribose) polymerase 1; PUFAs, polyunsaturated fatty acids; ROS, reactive oxygen species; SIRT-1, sirtuin (silent mating type information regulation 2 homolog) 1.
FIGURE 2
FIGURE 2. Anti-aging effects of caloric restriction in the cardiovascular system
The up-arrow notation indicates an improvement or increase while the down-arrow shows decrease or impairment of cardiovascular functions and pathologies. NO, nitric oxide.

Similar articles

Cited by

References

    1. National Center for Health Statistics. Health, United States, 2014: With Special Feature on Adults Aged 55–64. Hyattsville, Md: National Center for Health Statistics; 2015. pp. 2015–1232. - PubMed
    1. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence, risk factors The Framingham Heart Study. Ann Intern Med. 1988;108:7–13. - PubMed
    1. Schulman SP, Lakatta EG, Fleg JL, Lakatta L, Becker LC, Gerstenblith G. Age-related decline in left ventricular filling at rest and exercise. Am J Physiol. 1992;263:H1932–H1938. - PubMed
    1. Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109–1124. - PMC - PubMed
    1. Muscari C, Caldarera CM, Guarnieri C. Age-dependent production of mitochondrial hydrogen peroxide, lipid peroxides and fluorescent pigments in the rat heart. Basic Res Cardiol. 1990;85:172–178. - PubMed

Publication types

MeSH terms